Analgesic Strategies in Newborns Receiving Prostaglandin Therapy
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00200590
(More important number of SAE in one arms)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
up to 28 Days (Child)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Under one month of age
With ductus dependent congenital heart disease requiring prostaglandin infusion and elevated pain score
Contraindication to either morphine, acetaminophen, or nalbuphine